Clinical characteristics of patients with MCL in 2 different eras
| Characteristic . | Total (N = 343) . | Era 1 (n = 175) . | Era 2 (n = 168) . | P . |
|---|---|---|---|---|
| Sex | .64 | |||
| Female | 78 (22.7) | 38 (21.7) | 40 (23.8) | |
| Male | 265 (77.3) | 137 (78.3) | 128 (76.2) | |
| Age, y | ||||
| Median (range) | 64 (32-96) | 64 (41-95) | 64 (32-96) | .77 |
| ≤65 | 184 (53.6) | 93 (53.1) | 91 (54.2) | .85 |
| >65 | 159 (46.4) | 82 (46.9) | 77 (45.8) | |
| ECOG performance status | .44 | |||
| 0-1 | 309 (90.4) | 156 (89.1) | 153 (91.6) | |
| ≥2 | 33 (9.6) | 19 (10.9) | 14 (8.4) | |
| Missing | 1 | 0 | 1 | |
| Lactate dehydrogenase | .20 | |||
| Normal | 190 (67.1) | 88 (62.0) | 102 (72.3) | |
| Elevated | 93 (32.9) | 54 (38.0) | 39 (27.7) | |
| Missing | 60 | 33 | 27 | |
| sMIPI | .44 | |||
| Low (0-3) | 79 (27.6) | 44 (30.6) | 35 (24.6) | |
| Intermediate (4-5) | 105 (36.7) | 53 (36.8) | 52 (36.6) | |
| High (6-12) | 102 (35.7) | 47 (32.6) | 55 (38.7) | |
| Missing | 57 | 31 | 26 |
| Characteristic . | Total (N = 343) . | Era 1 (n = 175) . | Era 2 (n = 168) . | P . |
|---|---|---|---|---|
| Sex | .64 | |||
| Female | 78 (22.7) | 38 (21.7) | 40 (23.8) | |
| Male | 265 (77.3) | 137 (78.3) | 128 (76.2) | |
| Age, y | ||||
| Median (range) | 64 (32-96) | 64 (41-95) | 64 (32-96) | .77 |
| ≤65 | 184 (53.6) | 93 (53.1) | 91 (54.2) | .85 |
| >65 | 159 (46.4) | 82 (46.9) | 77 (45.8) | |
| ECOG performance status | .44 | |||
| 0-1 | 309 (90.4) | 156 (89.1) | 153 (91.6) | |
| ≥2 | 33 (9.6) | 19 (10.9) | 14 (8.4) | |
| Missing | 1 | 0 | 1 | |
| Lactate dehydrogenase | .20 | |||
| Normal | 190 (67.1) | 88 (62.0) | 102 (72.3) | |
| Elevated | 93 (32.9) | 54 (38.0) | 39 (27.7) | |
| Missing | 60 | 33 | 27 | |
| sMIPI | .44 | |||
| Low (0-3) | 79 (27.6) | 44 (30.6) | 35 (24.6) | |
| Intermediate (4-5) | 105 (36.7) | 53 (36.8) | 52 (36.6) | |
| High (6-12) | 102 (35.7) | 47 (32.6) | 55 (38.7) | |
| Missing | 57 | 31 | 26 |
All data are No. (%) unless otherwise specified.
ECOG, Eastern Cooperative Oncology Group.